Joint Filing AgreementJoint Filing Agreement • February 21st, 2014 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G, as amended, dated February 21, 2014 with respect to the shares of Common Stock of GenVec, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
AGREEMENT JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • August 23rd, 2024 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of Galapagos NV, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • September 18th, 2013 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G dated September 18, 2013 with respect to the shares of Common Stock of GenVec, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • December 20th, 2013 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G dated December 20, 2013 with respect to the shares of Common Stock of Kindred Biosciences, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13GJoint Filing Agreement • December 17th, 2024 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint EcoR1 Capital, LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exe
Joint Filing AgreementJoint Filing Agreement • October 8th, 2014 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G, dated October 8, 2014 with respect to the shares of Common Stock of Assembly Biosciences, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • February 17th, 2015 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Amendment No. 1 to Schedule 13G, dated February 17, 2015 with respect to the shares of Common Stock of Kindred Biosciences, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • August 29th, 2014 • EcoR1 Capital, LLC • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G, dated August 29, 2014 with respect to the shares of Common Stock of Transcept Pharmaceuticals, Inc. and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
